Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma

Chibby is an antagonist of β-catenin and is considered a potential tumor suppressor protein, but the role of Chibby in hepatocellular carcinoma (HCC) has not been characterized. The expression patterns of Chibby and β-catenin in HCC specimens and paired adjacent noncancerous tissues were measured by...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ming-Chao, Huang, Chao-Cheng, Wei, Yu-Ching, Liu, Ting-Ting, Lin, Ming-Tsung, Yi, Li-Na, Lin, Pey-Ru, Wang, Chih-Chi, Chu, Tian-Huei, Hsiao, Chang-Chun, Hu, Tsung-Hui, Tai, Ming-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139567/
https://www.ncbi.nlm.nih.gov/pubmed/32192213
http://dx.doi.org/10.3390/ijms21062060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139567/
https://www.ncbi.nlm.nih.gov/pubmed/32192213
http://dx.doi.org/10.3390/ijms21062060

Ejemplares similares